UNITED S'I¥&TES PATENT AND TRADEMARK OFFICE
`
`
`
`UNITED S'T'r‘\'TES DEPARTMENT OF ('OMMF}Rl".F
`United States Patent and Trademark l'Jffir-9
`Arid:-es::«:<’TI‘I1’\'1i\1IFiSif1_\J'l-7.13 FDR P.-‘\'l‘F!1*.i’i‘F;
`PO Box. [150
`Alexnmlm. \'1'.rpn'La 22.‘I3-1450
`vwt-1il'.u.=[yt(| gov
` APPLICATION NT_.T.\-'IBER FILING OR 371f_C1 DATE FIRST N.-UVIED APPLICANT ATTY. DOCKET NOITITLE
`101502.685
`0T;"2?r’2004
`Na_vna Govind
`100629-US-PCT
`CONFIRMATION NO. 7568
`
`
`
`
`
`
`
`44992
`ASTRAZEN ECA R&D BOSTON
`35 GATEHOUSE om
`WALTHAM. MA 02451-1215
`
`POWER OF ATTORNEY NOTICE
`
`mumiiiiiiiiigiiigiigiiiiigiiiiiigiiiiiiiiiiiiiiili
`
`Date Mailed: 07.’1 0f2014
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This iS in response to the Power Of Attorney filed 06r'24r’2014-.
`
`« The Power of Attorney to you in this application has been revoked by the applicant. Future correspondence
`will be mailed to the new address of record{37 CFH 1.33).
`
`fnlllurttct‘ nlylcsf
`
`Office of Data Management. Application Assistance Unit (571) 272-4000. or (571) 272-4200. or 1-888-786-0101
`
`page1of1
`
`Complex Ex. 1002, part 1
`Complex Ex. 1002, part 1
`of 2
`of 2
`
`
`1
`
`1
`
`

`
`vim-1lt',tI,=[,vt(I gov
`
`UNTPFID STATES DEPARTMENT OF f'OMi\1FIRl".F
`United States Pawmt and Trademark Dffioe
`Altai-ess:fTo1\'11\1IFiF11O_\1'EE FDR PA"l‘F!N'l‘F;
`PO Box. [450
`Alexnnilm. \'1'.tg:nLa 22.113-1-150
`
`]0l'5-02.685
`
`0?f2?i’2004
`
`Na_vna Govind
`
`056291-5543
`CONFIRMATION N0. 7568
`
`9629
`
`MORGAN LEWIS 8 BOCKIUS LLP (WA)
`1111 PENNSYLVANIA mug NW
`WASHINGTON. DC 20004
`
`POA ACCEPTANCE LETTER
`
`lllllllllllllllIllllligmgllgllflliglijjliligillllllllllllllllllll
`
`Date Mailed: 07,11 0.12014
`
`NOTICE OF ACCEPTANCE OF POWEFI OF ATTORNEY
`
`This is in response to the Power of Attorney filed 05l"24l’2014.
`
`The Power of Attorney in this application is aooepted. Correspondence in this application will be mailed to the
`above address as provided by 37 CFR 1 .33.
`
`fnnrtlrller nlylesi
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page1of1
`
`2
`
`

`
`
`
`PTO!SBi'81A {"1206}
`Approved for use through 11i‘3Dr’2fJ11. OMB 0551-0035
`US Patent and Tradernark Otficez US. DE PAFETMENT OF COMMERCE
`L|1'HJEl the Paperwork Reduction Act of 1995. no persons are required to respond to a coileclion Oi infornmation unless it displays at valid OMB control number.
`7".759.328
`
`’°a‘°“* “”""°°'
`PATENT . POWER OF ATTORNEY
`issue Date
`OR
`REVOCATION OF POWER OF ATTORNEY f‘”"”“’”‘°"‘ ‘”"e”‘°'
`WETH A NEW POWER OF ATTORNEY
`AND
`
`CHANGE OF CORRESPONDENCE ADDRESS
`
`E] A Power offittlomey is submitted herewith.
`OR
`
`I hereby appoint Practitioriertst associated with the following Customer Number as mytour
`attorrisytsi or agentfsi with respect to the patent identified above. and to transact all business in
`the United States Patent and Trademark Office connected therewith:
`
`Q9529
`
`thereby appoint Prectitionertsi named below as myiour attorneyts) Or agentfis) with respect to the patent identified
`above. and to transact all business in the United States Patent and Trademark Office connected therewith:
`
`P"=‘l01ifi°t"9i'($) Nama
`
`Registration Number
`
`Please recognize or change the correspondence address for the above-identified patent to:
`
`E The address associated with the above-mentioned Customer Number.
`OR
`
`The address associated with Customer Number;
`‘oz:
`,.
`
`
`
`_
`
`.
`
`..
`
`......._.
`
`i'
`
`i
`
`‘ | | |
`
`L‘;
`l'-'irrn or
`Individual Name
`Address
`
`City
`
`Eon ntry
`Telephone
`I am the:
`
`Inventor, having O-wnerslfip of the pate rit.
`R
`
`Patent owriar.
`L-J Sta.-teirient under 3? CF)? 3. T3r'b) {Form PTOi’.'SB.-"9l5) submitted here with or riled On
`
`[~t_g_1‘__E;: Signatures Oi alt the inventors or patent owners of the entire interest or their rapresenlativets} are required. Sui:-mi! muihpte loriris it more than one
`signature is required, see betow‘.
`
`forms are submitted.
`
`This collection ortnrcrrnation is raqurred by 3? CFR 1.3]. 1.32 and 1.33. The information is required to ODlt:‘Iit'l Or retain a benefit by the public which is to lite {and by the
`USPTO to process) an application. can firlienliality is governed by 35 EJ.8.C. 127. and 3? CFR ‘i 11 and 1 14. This ooltection I5 estimated to take 3 minutes to Oompiete.
`inctudtng gi;mgri>t-.g_ p|'epa|‘ing‘ and suhinitting the completed application town to the USPTO. Time will vary depending upon the inrlliridual case. any oamments on
`the amount OI time you require to complete this form nnflror suggestions for reducing this burden. should be sent to the Chief Information Officer. U.S. Patent and
`Trademark Office. US. Department of Commerce, l’-‘.0. 30>.‘ ‘I450. mexandria. Wt 22313-1460. DO NOT SEND FEES OR COMF'LETED FORMS T0 TH|3
`ADDRESS. BENI3 TO: Commissioner for Fatents. PO. Box $4.50, mexanctria. VA 223134-t5Ci.
`
`if you need assistance in completing the form. cat! 1-800-PTO-9199 and select option 2.
`
`3
`
`

`
`P‘|'Cri’3Bi|'9fi (0?-09}
`Approved for use through 0‘.-'!31l2fl1 2. OMB 0651-0031
`US. Patent and Trademark Office-; U.S_ DEPARTMENT OF COM MERGE
`Under the ?a rwork Reduction not of 15395, no oreoris are r uirect to respond to oi ooilcotiun ul
`information unless it ill" ' a S a valid OMB control number.
`
`
`
` AppIicantiPalenl0wner: G°Vind eta‘-
`
`
`STATEMENT UNDER 3? CFR 3.?3jb[
`
`.. ..
`
`_ Filedris-sue Date:
`
`.4.E.‘.'.3.{..%.‘?.: ..?9.1.°
`
`
`Fippticafon N0~iPaienl N0-I _?.-.3§9a??.3..
`Tified‘.
`
`Composition For Inhalation
`
`
`
`
`
`a
`
`corporation
`{Type otA.-asignee. e.g.. corporation, partr-iersiiip, university. gtwernrrierit agericy. etc.
`
`
`
`Astrezeneca AB
`(Harrie of A:-.sigi1ee;
`
`
`
`D an essignee of fess than the entire right. title, and interest in
`(The extent (by percentage) of its ownership interest is
`
`‘M; or
`
`
`
`slates that it is:
`
` 1.
`the assignee of the entire right. title. and interest in;
`
`3
`i__i
`the assignee of on undivided interest in the entirely of (a complete assignment from one of the joint inventors was made}
`
`
` the patent appiicaticnipatent identified above. by virtue of either:
`
`
`
`
`A.
`An assignment from the irwentortsl of the patent appticotionlpaterat identified above. The assignment was recorded in
`. or for which a
`the United States Patent and Trademark Office at Real
`015506
`. Frame 0145
`copy therefore is attached.
`
`
`
`
`on
`
`e. f]
`
`A chain oftille from the invenl;or(s). of the patent eppiioationipateiit identified above. iCl the current assignee as follows:
`1. From:
`To:
`
`_H_“
`
`The document was recorded in the United States Patent and Trademark Office at
`
`
`
`
`Reei
`_
`Frame
`.
`or for which a copy thereof is attached.
`
` 2. From. To:
` The document was recorded in the United States Patent and Tradeinark Office at
`
`
`
`Reel
`.
`Frame___
`.
`orforwhichacopythereofisattaciied.
` 3. From: To:
`
`The document was recorded in the United States Patentand Trademark Office at
`
`.
`
`Frame
`
`,
`
`or for which ai copy thereof is attached.
`
`
`
`Additional documents in the chain of title are listed on a supplemental sheettsi.
`
` :1
`
`
`
`
`
`
`
`E] As required by 37 CFR 3 ?3{t-}(1](i). the documentary evidence of the chain ol title trom the original owner to the assignee was.
`or concurrently is being. submitted for recordation pursuant to 3? CFR 3.11.
`
`
`
`
`
`
`mg.“ .i,,.mQli
`
`3'8
`(1
`
`Patent Attorney. Astrazenefi
`Meaghan L, Richmond; Reg. No. 81402
`
` “'
`--—~—*-7-mm“--—
`Printed or Typed Name
`This colleoiicrr of inlormfilloii is required by 3?’ CFR Li«.i'3tb}. The inlorrnatiori is reqtrlretl to obtain orretain a Deiiefit by the public which is 10 lile (and by the USPTO I0
`process) an application. Ccnladentialily is governed by 35 U.S.C. 1122 and 3-? CFR 1.11 and 1.14 Th is collection IS estimated to take i2 minutes to complete, including
`gathering, preparing, and submilli rig true coiiririletr-.d opplicatioii form to the USPTD. Time will vaiy depending upon the individual case. Ami DD|'1'1l'l!BfllS on the amount cl lime
`you require to complete this term anuror suggestroris for rsoucing this burden, should be sent to the Chiet lntormetion Officer. US. Patent and Trademark Office, US.
`Department of Conimiarco PO. Box 1450, Atoxacdria. VA 22313-1450. 00 NOT SEND FEES OR COMPLETED FORMS T0 THlS ADDRESS SEND TO: Commissioner
`for Putenls, P.O. Box 1450. Alaxanclrla, VA 22313-1450.
`
`{NOTE: A separate copy (lie-.. a true copy of the originsii assignment ciocumentlsjii must be submitted to Assignment Division in
`accordance with 3? CFR Part 3. to record the assignment in the records ofthe USPTO. §g MPEP 302.05]
`
`The undersigned (whose titl
`
`'
`
`supplied bo1¢:aw)is authorized to act on behalf of the assigrieie.
`
`
`W
`
`2Li
`
`Date
`
`1.13:9“ migd assistance r'.r.i cwnpreiirig the form. Gaff l‘-i3OG~F>T0—£t F99 and seiec-I option 2
`
`4
`
`4
`
`

`
`Electronic Acknowledgement Receipt
`
`EF5 ID:
`
`19398477
`
`Application Number:
`
`10502685
`
`International Application Number:
`
`Confirmation Number:
`
`7568
`
`Title of Invention:
`
`COMPOSITION FOR INHALATION
`
`First Named lnventorfllpplicant Name:
`
`Nayna Govind
`
`Customer Number:
`
`44992
`
`Filer:
`
`Gregory Thomas Lowen
`
`Filer Authorized By:
`
`Attorney Docket Number:
`
`100629-US-PCT
`
`Receipt Date:
`
`24-JUN-2014
`
`Filing Date:
`
`27-JUL-2004
`
`Time Stamp:
`
`18:03:42
`
`Application Type:
`
`u.s. National Stage under 35 USC 371
`
`Payment information:
`
`Submitted with Payment
`
`no
`
`File Listing:
`
`
`
`File Size{Bytes).-'
`Message Digest
`90895
`
`Pages
`'
`Part Lzip [if appI.]
`
`
`Power of Attorney
`5S43POA.pdf
`no
`:20BTI»-lb2adFklaI'}ceced?32-I§d2d739aTflS
`'|el7'a
`
`1
`
`.
`.
`Document Descflpflon
`
`Document
`Number
`
`1
`
`Warnings:
`
`Info rmation:
`
`5
`
`5
`
`

`
`2
`
`Warnings:
`Information:
`
`Assignee showing of ownership per 37
`
`CFR 3773'
`
`5543Staten'Ient.pdf
`
`c9ISa77i15iec3n3aD-1d?23SbdaBb1 I9.-aicl
`97:3
`
`no
`
`1
`
`I
`I
`
`Total Files Size [in bytes):|
`
`173194
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Ca rd, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 1 1 1
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-[d] and MPEP 506], a Filing Receipt [37 CFR 1.54] will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date ofthe application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirementsa Form PCT.-“D0.~'E02'903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date [see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date [Form PCTfR0.~'105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`
`6
`
`

`
`vim-1l|',tI,=[,vt(I gov
`
`UNTPFID ST-QTES DEPARTMENT OF f'OMMFIRl".F
`United States Pawmt and Trademark Offioe
`Attdi-es<s«:tTI‘|1\'11\1IFiF11f1_\1'i7.E FDR PA"l‘F!N'l‘F;
`P0 Bar. [450
`Alexnnilm. \'1'.tg:nLa 22.1! 3-1450
`
`101502.685
`
`OTIZWZOO4
`
`Na_vna Govind
`
`100629-US-PCT
`CONFIRMATION N0. 7568
`
`44992
`ASTRAZEN ECA Fl&D BOSTON
`
`35.Ae$gmo'o1il50£,4R5.~1.,§215
`
`POA ACCEPTANCE LETTER
`
`lllilllllIiIlltitlgiigltiliglgiilillglllillliliulnll
`
`Date Mailed: 06.’09:’2014
`
`NOTICE OF ACCEPTANCE OF POWEFI OF ATTORNEY
`
`This is in response to the Power of Attorney filed 052812014.
`
`The Power of Attorney in this application is aooepted. Correspondence in this application will be mailed to the
`above address as provided by 37 CFR 1 .33.
`
`fnnrtirller nlylesf
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page1of1
`
`7
`
`

`
`vwt-1it',t,I,=[,vt(I gov
`
`UNTPFID STATES DEPARTMENT OF f'OMI\1FIRl".F
`United States Pawmt and Trademark Offioe
`Attdu-es<s«:tTI‘|I\'II\1IFiF1IO_\1'I7.E FDR PA"l‘F!N‘T‘FI
`PO Box. I450
`Alexnnilm. \'1'.tg:nLa 22.1! 3-1-I50
`
`101502.685
`
`0?f2?t’2004
`
`Naytta Govind
`
`9629
`
`MORGAN LEWIS 8 BOCKIUS LLP (WA)
`1111 PENNSYLVANIA mug NW
`WASHINGTON. DC 20004
`
`CONFIRMATION NO. 7568
`
`POWER OF ATTORNEY NOTICE
`
`tuttitItIlttgtttgttgtttttgttttttttlIttttlltnt
`
`Date Mailed: 06.’09t’2014
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This is in response to the Power Of Attorney tiled 05f28t’201«’-I-.
`
`« The Power of Attorney to you in this application has been revoked by the applicant. Future oorrespondence
`will be mailed to the new address of reoord(37 CFR 1.33).
`
`frmlu 111:1‘ tuylcsf
`
`Office of Data Management. Application Assistance Unit (571) 272-4000. or (571) 272-4200. or 1-888-786-0101
`
`page1of1
`
`8
`
`

`
`F'TOi5Eir'B1.A (12-03)
`Appmved for use through 11t3l].i2(]11 _ OMB 0651-0035
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Actor 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`PATENT . POWER 0|: ATTORNEY
`OR
`REVOCATTON 0.: POWER 0.: ATTORNEY
`
`AND
`CHANGE °F °°R"ES"°“°E“°E ADDRESS
`
`I hereby revoke all previous powers of attorney given in the above-identified patent.
`
`D A Power of Attorney is submitted herewith.
`OR
`
`I hereby appoint Practitioner(s) associated with the following Customer Number as myiour
`attorney(s) or agent{s) with respect to the patent identified above, and to transact all business in
`the United States Patent and Trademark Office connected therewith:
`
`44992
`
`El
`
`I hereby appoint Practitioner(s) named below as mytour attorney(s) or agent(s) with respect to the patent identified
`above. and to transact all business in the United States Patent and Trademark Office connected therewith:
`
`F’ifi°tiii0"'ei(5) Name
`
`Registration Number
`
`Please recognize or change the correspondence address for the above-identified patent to:
`
`The address associated with the above-mentioned Customer Number.
`OR
`
`CI The address associated with Customer Number:
`OR
`Firm or
`Individual Name
`
`
`
` —
`
`Telephone
`I am the:
`
`Inventor, having ownership of the patent.
`El
`OR
`
`I
`Patent owner.
`Statement under 37 CFR 3. 73th) (Form PTO-/SB/96) submitted herewith or flied on
`SIGNATURE of Inventor or Patent Owner
`
`Title and Com an
`
`Meaghan L. Richmond!
`Meaghan L. Richmond
`Patent Attomey; Astrazeneca AB
`
`Telephone
`
`May 23, 2014
`+1 131.339.4054
`
`ll-lL'l_'|'_E: Signatures of all the inventors or patent owners of the entire interest or their representativets) are required. Submit multiple fonns it more than one
`signature is required, see below‘.
`
`forms are submitted.
`1
`*Total of
`This collection of infon‘naLion is required by 3? CFR 1.31, 1.32 and 1.33. The information is required to obtain or retain a benefit by the public which is to file [and by the
`USPTO to process} an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1,11 and 1.14. This collection is estimated to take 3 minutes to complete.
`including gathering. preparing. and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
`the amount of time you require to complete this form andfor suggestions for reducing this burden, should be sent to the Chief Information Officer, U_S_ Patent and
`Trademark Orifice, U.S. Department of Commerce, PO. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
`ADDRESS. SEND TO: Commissioner for Patents. P.O. Box 1450, Alexandria. VA 22313-1450.
`
`ifyou need assistance in oompieting the form. cal! 1‘-800-PTO-9199 and select option 2.
`
`9
`
`9
`
`

`
`Privacy Act Statement
`
`The Privacy Act of 1974 (EL. 93-579) requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent. Accordingly,
`pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
`collection of this information is 35 U.S.C. 2(b)(2}; (2) furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the US. Patent and Trademark
`Office is to process andfor examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`process andfor examine your submission, which may result in termination of proceedings or
`abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the
`Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
`this system of records may be disclosed to the Department of Justice to determine whether
`disclosure of these records is required by the Freedom of Information Act.
`in the course of
`A record from this system of records may be disclosed, as a routine use,
`presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
`opposing counsel in the course of settlement negotiations.
`to a Member of
`A record in this system of records may be disclosed, as a routine use,
`Congress submitting a request involving an individual, to whom the record pertains, when the
`individual has requested assistance from the Member with respect to the subject matter of the
`record.
`
`A record in this system of records may be disclosed. as a routine use, to a contractor of the
`Agency having need for the information in order to perform a contract. Recipients of
`information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in
`this system of records may be disclosed, as a routine use, to the International Bureau ofthe
`World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal
`agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
`the Atomic Energy Act (42 U.S.C. 218(0)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator,
`General Services. or hisfher designee. during an inspection of records conducted by GSA as
`part of that agency's responsibility to recommend improvements in records management
`practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
`be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i'.e., GSA or Commerce) directive. Such disclosure shall not
`be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after
`either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
`pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public ifthe record was filed in an application which
`became abandoned or in which the proceedings were tenninated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State,
`or local law enforcement agency, if the USPTO becomes aware of a violation or potential
`violation of law or regulation.
`
`10
`
`10
`
`

`
`PTOfSBf‘.:'lfi (0?-O9]
`Approved for use through 0Ir'f31l2012 OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`STATEMENT UNDER 37 CFR 3.73§bl
`
`Applicantr'Patent Owner: G5-""i"d et 3'-
`
`Application No.!Patent No.: 7»759328
`Titled
`
`COMPOSITION FOR INHALATION
`
`Astrazeneca AB
`[Name of Assignee)
`
`states that it is:
`
`Filedflssue Date: 20 Jul)’ 2010'
`
`_ a
`
`Corporation
`[Type of Assignee, e.g., corporation, partnership, university, govemrnent agency, etc.
`
`1,
`
`the assignee of the entire right, title, and interest in;
`
`2. D an assignee of less than the entire right, title, and interest in
`(The extent (by percentage) of its ownership interest is
`
`%); or
`
`3, D the assignee of an undivided interest in the entirety of (a complete assignment from one of the joint inventors was made)
`
`the patent applicationfpatent identified above, by virtue of either:
`
`A.
`
`OR
`
`An assignment from the inventor(s) of the patent applicationlpatent identified above. The assignment was recorded in
`the United States Patent and Trademark Office at Reel 015506
`, Frame 0145
`, or for which a
`copy therefore is attached.
`
`B. D A chain of title from the inventor(s). of the patent application.-‘patent identified above, to the current assignee as follows:
`1. From:
`To:
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`,
`
`Frame
`
`,
`
`or for which a copy thereof is attached.
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`,
`
`Frame
`
`,
`
`or for which a copy thereof is attached.
`
`To:
`
`To:
`
`2. From:
`
`3. From:
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`,
`
`Frame
`
`,
`
`or for which a copy thereof is attached.
`
`E Additional documents in the chain of title are listed on a supplemental sheet(s).
`
`As required by 37 CFR 3.73(b}(1)(i}. the documentary evidence of the chain of title from the original owner to the assignee was,
`or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11.
`
`[NOTE: A separate copy (r'.e., a true copy of the original assignment document(s)) must be submitted to Assignment Division in
`accordance with 37 CFR Part 3. to record the assignment in the records of the USPTO. E MPEP 302.08]
`
`The undersigned (whose title is supplied below) is authorized to act on behalf of the assignee.
`
`flvteaghan L. Richmond!
`
`Signature
`
`May 23, 2014
`
`Date
`
`Meaghan L. Richmond; Reg no. 61402
`
`Patent Attorney, Astrazeneca
`
`Title
`Printed orT ped Name
`This collection of infomlafion is required by 37 CFR 3.73(b). The infom1alion is required to obtain or retain a benefit by the public which is to tile {and by the USPTO to
`process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR I .1 1 and 1.14. This collection is eatirnated to take 12 min utes to oomplete, including
`gathering. preparing. and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time
`you require to complete this form andfor suggestions for reducing this burden. should be sent to the Chief Information Officer. US. Patent and Trademark Office. US.
`Department of Commerce. PO. Box 1450. Alexandria. VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner
`
`1 1
`for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`if you need assfstalaoe in completing the form. call 1-800-PTO-9199 and select option 2.
`
`11
`
`

`
`Privacy Act Statement
`
`The Privacy Act of 1974 (PL. 93-579) requires that you be given certain information in connection
`with your submission of the attached form related to a patent application or patent. Accordingly,
`pursuant to the requirements of the Act. please be advised that: (‘l) the general authority for the
`collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
`and (3) the principal purpose for which the information is used by the US. Patent and Trademark
`Office is to process andior examine your submission related to a patent application or patent. If you do
`not furnish the requested information, the US. Patent and Trademark Office may not be able to
`process andior examine your submission. which may result in termination of proceedings or
`abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the
`Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
`this system of records may be disclosed to the Department of Justice to determine whether
`disclosure of these records is required by the Freedom of Information Act.
`in the course of
`A record from this system of records may be disclosed, as a routine use,
`presenting evidence to a oourt, magistrate, or administrative tribunal, including disclosures to
`opposing counsel in the oourse of settlement negotiations.
`to a Member of
`A record in this system of records may be disclosed, as a routine use,
`Congress submitting a request involving an individual, to whom the record pertains, when the
`individual has requested assistance from the Member with respect to the subject matter of the
`record.
`A record in this system of records may be disclosed, as a routine use, to a contractor of the
`Agency having need for the information in order to perform a contract. Recipients of
`information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in
`this system of records may be disclosed, as a routine use, to the International Bureau ofthe
`World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed. as a routine use. to another federal
`agency for purposes of National Security review (35 USC. 181) and for review pursuant to
`the Atomic Energy Act (42 U.S.C. 218(c)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator,
`General Services, or hisfher designee, during an inspection of records conducted by GSA as
`part of that agency's responsibility to recommend improvements in records management
`practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
`be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
`be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after
`either publication of the application pursuant to 35 U.S.C. l22(b) or issuance of a patent
`pursuant to 35 U.S.C. 151. Further. a record may be disclosed. subject to the limitations of 37
`CFR 1.14, as a routine use, to the public ifthe record was filed in an application which
`became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspection or an
`issued patent.
`A record from this system of records may be disclosed, as a routine use. to a Federal, State.
`or local law enforcement agency, if the USPTO becomes aware of a violation or potential
`violation of law or regulation.
`
`12
`
`12
`
`

`
`Electronic Acknowledgement Receipt
`
`EF5 ID:
`
`19150674
`
`Application Number:
`
`10502685
`
`International Application Number:
`
`Confirmation Number:
`
`7568
`
`Title of Invention:
`
`COMPOSITION FOR INHALATION
`
`First Named lnventorfllpplicant Name:
`
`Nayna Govind
`
`Customer Number:
`
`9629
`
`Filer:
`
`Meaghan Lynn Richmond/Ja mi Baumer
`
`Filer Authorized By:
`
`Meaghan Lynn Richmond
`
`Attorney Docket Number:
`
`Receipt Date:
`
`28-MAY-2014
`
`Filing Date:
`
`27-JUL-2004
`
`Time Stamp:
`
`17:09:34
`
`Application Type:
`
`u.s. National Stage under 35 USC 371
`
`Payment information:
`
`Submitted with Payment
`
`no
`
`File Listing:
`
`
`
`File Size{Bytes).-'
`Message Digest
`74?089
`
`Pages
`'
`Part Lzip [if appI.]
`
`
`Power of Attorney
`PowerSB81A.pdf
`no
`59-3cll04?'4l'ltl 3rla37FIf'.|'52d8F?'9020d2?{9
`N899
`
`2
`
`.
`.
`Document Descflpflon
`
`Document
`Number
`
`1
`
`Warnings:
`
`Info rmation:
`
`L3
`
`13
`
`

`
`2
`
`Assignee showing of ownership per 37
`CFR 3773'
`
`Staten1entSB96.pdf
`
`
`AO6§D1ac06?'6?'e|'J2c3f8r.c4av61bF3a2IS'|'|
`e-636
`
`no
`
`2
`
`422936
`
`Warnings:
`Information:
`
`I
`I
`
`Total Files Size [in bytes):|
`
`1170025
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Ca rd, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 1 1 1
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-[d] and MPEP 506], a Filing Receipt [37 CFR 1.54] will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date ofthe application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirementsa Form PCT.-“D0.~'E02'903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date [see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date [Form PCTfR0.~'105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`
`14
`
`14
`
`

`
`vim-1lt',tI,=[,vt(I gov
`
`UNTPFID STATES DEPARTMENT OF f'OMi\1FIRl".F
`United States Patent and Trademark Dffioe
`Att<l|'£s<s<: fTI‘|1\'1l\1IFiF11O_\1'EE FDR PA"l‘F!N'l‘F;
`PO Box. [450
`Alexnnilm. \'1'.tg:nLa 22.1! 3-1450
`
`101502.685
`
`0?f2?i’2004
`
`Na_vna Govind
`
`9629
`
`MORGAN LEWIS 8 BOCKIUS LLP (WA)
`1111 PENNSYLVANIA mug NW
`WASHINGTON. DC 20004
`
`CONFIRMATION N0. 7568
`
`POA ACCEPTANCE LETTER
`
`lllllllllllllllIllllligmgllgliflliglflllimilllllllllllllllllll
`
`Date Mailed: 03.’03f2014
`
`NOTICE OF ACCEPTANCE OF POWEFI OF ATTORNEY
`
`This is in response to the Power of Attorney filed 02l"12l’2014.
`
`The Power of Attorney in this application is aooepted. Correspondence in this application will be mailed to the
`above address as provided by 37 CFR 1 .33.
`
`ftrwoodsollf
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page1of1
`
`15
`
`15
`
`

`
`vwt-1it',tI,=[,vt(I gov
`
`UNTPFID STATES DEPARTMENT OF f'OMMFIRl".F
`United States Patent and Trademark Dffioe
`Attdu-ess:iTI\1\1I\1IFiF1V1_\1'EE FDR PA"l‘F!N‘T‘F;
`PO Box. [450
`Alexnnilm. \'1'.tg:nLa 22.1! 3-1450
`
`101502.685
`
`OTIZWZOO4
`
`Na_\_ina Govind
`
`062?5—410USl
`CONFIRMATION NO. 7568
`
`26164
`FISH 8: RICHARDSON P.C.
`
`Emggpgfigs MN SW 022
`
`POWER OF ATTORNEY NOTICE
`
`HllllliilliiiIiillligmgligiifliigigiiiitgigliHlillliilllllllli
`
`Date Mailed: 03.’03:’2014
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 02i''12i’2014.
`
`« The Power of Attorney to you in this application has been revoked by the assignee who has intervened as
`provided by 37 CFR 3.71. Future correspondence will be mailed to the new address of reoord{37 CFR 1.33).
`
`2’lrwoodso11J'
`
`Office of Data Management. Application Assistance Unit (571) 272-4000. or (571) 272-4200. or 1-888-786-0101
`
`page1of1
`
`16
`
`16
`
`

`
`PTDIAFNBO {fl?—1 2'3
`Applovafi fol use uwrough ’l1»’3‘3r'20'|-Ii. OP-£8 0651-0035
`U.S. Patent and ‘l'rada.':=a(k Otfi-:5; UJS [!EEP.M'-£‘l'MENT (BF -:3:Z3h.*.Pu1EflC:£E
`Under {:15 Papennark Reduciican A5? cf 19? 5. no persons are mzgttirec lo resyrmd to 3 crailrsctlar: 0! i:1forrn;atin:1 uniesrs '11 (jispisys a valid OMB .'.‘,1;;nimi n:Jrr‘.he:-r.
`
`_
`
`PQWER Cl AWORNEY T0 FRGSECEJTE APPL!{3ATEC3N$ BEFGRE THE USFFO
`
`1 hereby revoke .3}! previous powers -of aiiorne
`. ”"de £Q%W........................................................................
`_
`i hereby appsirstt
`I g E
`Pres-::z.i:'anners associsied with Customer Number:
`{JR
`
`tatesenene
`
`As attorneyis) (.1:-ag